Routine single particle CryoEM sample and grid characterization by tomography
- New York Structural Biology Center, United States
- City College of New York, United States
- Columbia University, United States
- National Institutes of Health, United States
Abstract
Single particle cryo-electron microscopy (cryoEM) is often performed under the assumption that particles are not adsorbed to the air-water interfaces and in thin, vitreous ice. In this study, we performed fiducial-less tomography on over 50 different cryoEM grid/sample preparations to determine the particle distribution within the ice and the overall geometry of the ice in grid holes. Surprisingly, by studying particles in holes in 3D from over 1,000 tomograms, we have determined that the vast majority of particles (approximately 90%) are adsorbed to an air-water interface. The implications of this observation are wide-ranging, with potential ramifications regarding protein denaturation, conformational change, and preferred orientation. We also show that fiducial-less cryo-electron tomography on single particle grids may be used to determine ice thickness, optimal single particle collection areas and strategies, particle heterogeneity, and de novo models for template picking and single particle alignment.
Data availability
Several representative tilt-series from the datasets have been deposited to the Electron Microscopy Data Bank (EMDB) in the form of binned by 4 or 8 tomograms and to the Electron Microscopy Pilot Image Archive (EMPIAR) in the form of unaligned tilt-series images (one including super-resolution frames), Appion-Protomo tilt-series alignment runs, and aligned tilt-series stacks.Protomo estimations for the orientation of the local ice normal based on the tilt-series alignment of the particles in the ice, which includes potential systematic stage and beam axis error, are available in all deposited EMPIAR datasets as a plot located: protomo_alignments/tiltseries####/media/angle_refinement/series####_orientation.gifA Docker-based version of Appion-Protomo fiducial-less tilt-series alignment is available at http://github.com/nysbc/appion-protomo.
Article and author information
Author details
Funding
Simons Foundation (SF349247)
- Clinton S Potter
- Bridget Carragher
National Institutes of Health (R01 GM084162)
- David Jeruzalmi
New York State Foundation for Science, Technology and Innovation
- Clinton S Potter
- Bridget Carragher
National Institute of General Medical Sciences (GM103310)
- Clinton S Potter
- Bridget Carragher
Agouron Institute (F00316)
- Clinton S Potter
- Bridget Carragher
National Institutes of Health (S10 OD019994-01)
- Clinton S Potter
- Bridget Carragher
National Institute on Minority Health and Health Disparities (5G12MD007603-30)
- David Jeruzalmi
National Institute of Allergy and Infectious Diseases (Intramural Funding from the Vaccine Research Center)
- Peter D Kwong
Agency for Science, Technology and Research
- Yong Zi Tan
National Institutes of Health (R01-MH1148175)
- Lawrence Shapiro
The authors declare that the funders played no role in this work, including the experimental design, data collection, or data analysis.
Reviewing Editor
- Axel T Brunger, Stanford University Medical Center, United States
Publication history
- Received: December 12, 2017
- Accepted: May 17, 2018
- Accepted Manuscript published: May 29, 2018 (version 1)
- Version of Record published: June 13, 2018 (version 2)
Copyright
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Metrics
-
- 13,443
- Page views
-
- 1,965
- Downloads
-
- 137
- Citations
Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Routine single particle CryoEM sample and grid characterization by tomography
eLife 7:e34257.
https://doi.org/10.7554/eLife.34257
Further reading
-
- Computational and Systems Biology
- Structural Biology and Molecular Biophysics
The design of compounds that can discriminate between closely related target proteins remains a central challenge in drug discovery. Specific therapeutics targeting the highly conserved myosin motor family are urgently needed as mutations in at least 6 of its members cause numerous diseases. Allosteric modulators, like the myosin-II inhibitor blebbistatin, are a promising means to achieve specificity. However, it remains unclear why blebbistatin inhibits myosin-II motors with different potencies given that it binds at a highly conserved pocket that is always closed in blebbistatin-free experimental structures. We hypothesized that the probability of pocket opening is an important determinant of the potency of compounds like blebbistatin. To test this hypothesis, we used Markov state models (MSMs) built from over 2 milliseconds of aggregate molecular dynamics simulations with explicit solvent. We find that blebbistatin’s binding pocket readily opens in simulations of blebbistatin-sensitive myosin isoforms. Comparing these conformational ensembles reveals that the probability of pocket opening correctly identifies which isoforms are most sensitive to blebbistatin inhibition and that docking against MSMs quantitatively predicts blebbistatin binding affinities (R2=0.82). In a blind prediction for an isoform (Myh7b) whose blebbistatin sensitivity was unknown, we find good agreement between predicted and measured IC50s (0.67 mM vs. 0.36 mM). Therefore, we expect this framework to be useful for the development of novel specific drugs across numerous protein targets.
-
- Structural Biology and Molecular Biophysics
Proton-activated chloride (PAC) channel is a ubiquitously expressed pH-sensing ion channel, encoded by PACC1 (TMEM206). PAC regulates endosomal acidification and macropinosome shrinkage by releasing chloride from the organelle lumens. It is also found at the cell surface, where it is activated under pathological conditions related to acidosis and contributes to acid-induced cell death. However, the pharmacology of the PAC channel is poorly understood. Here, we report that phosphatidylinositol (4,5)-bisphosphate (PIP2) potently inhibits PAC channel activity. We solved the cryo-electron microscopy structure of PAC with PIP2 at pH 4.0 and identified its putative binding site, which, surprisingly, locates on the extracellular side of the transmembrane domain (TMD). While the overall conformation resembles the previously resolved PAC structure in the desensitized state, the TMD undergoes remodeling upon PIP2-binding. Structural and electrophysiological analyses suggest that PIP2 inhibits the PAC channel by stabilizing the channel in a desensitized-like conformation. Our findings identify PIP2 as a new pharmacological tool for the PAC channel and lay the foundation for future drug discovery targeting this channel.
